IP Library Granted Patent US 11,484,662
Granted Patent B2
US 11,484,662 · App. 15/778,263 · Granted Nov 1, 2022

Medicament injection device

Inventors: Michael Jugl (Frankfurt am Main, DE); Axel Teucher (Frankfurt am Main, DE); Stefan Blancke (Frankfurt am Main, DE); Michael Helmer (Frankfurt am Main, DE); Marc Schader (Frankfurt am Main, DE); Sebastian Braun (Darmstadt, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/3202A61M5/24A61M5/178A61M5/20A61M5/348A61M2005/2474
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,484,662
App. No.
15/778,263
Granted
Nov 1, 2022
Kind
B2
Abstract

A medicament delivery device comprising: a main body arranged to receive a medicament cartridge sealed with a penetrable barrier; a needle carrier carrying a needle; a cap removably coupled to the needle carrier, a pre-stressed spring connected to the needle carrier and to the main body, wherein the pre-stressed spring is held by an activation element coupled to the cap, wherein the activation element is arranged to release the spring when the cap is pulled in a distal direction from the device, thereby causing the needle carrier to move axially in a proximal direction.

Claims (22)

1. A medicament delivery device, comprising:

a main body arranged to receive a medicament cartridge sealed with a penetrable barrier;

a needle holder directly coupled to and carrying a needle;

a cap removably coupled to the needle holder; and

a pre-stressed spring connected to the needle holder and to the main body,

wherein when the pre-stressed spring is held in a pre-stressed state by an activation element, the activation element is directly coupled to the cap and to the main body or directly coupled to the cap and to the pre-stressed spring, prior to any movement of the cap in a distal direction away from the medicament delivery device, and

wherein the activation element is arranged to release the pre-stressed spring from the pre-stressed state when the cap is pulled in the distal direction from the medicament delivery device, thereby decoupling the activation element from the main body if the activation element is directly coupled to the cap and to the main body in the pre-stressed state, or from the pre-stressed spring if the activation element is directly coupled to the cap and to the pre-stressed spring in the pre-stressed state, and causing the needle holder to move axially in a proximal direction.

2. The medicament delivery device of claim 1 , wherein the needle holder comprises a cup-shaped part configured to form a frictional fit with the medicament cartridge.

3. The medicament delivery device of claim 2 , wherein the cup-shaped part has a lip to grip the medicament cartridge or a cartridge holder.

4. The medicament delivery device of claim 1 , further comprising a needle shield for shielding a distal end of the needle, wherein the needle shield is arranged to be fixed to the cap and removable from the needle.

5. The medicament delivery device of claim 1 , wherein the main body comprises a cartridge holder for receiving the medicament cartridge.

6. The medicament delivery device of claim 5 , wherein the pre-stressed spring is a constant force spring fixed, at a first end thereof, to the cartridge holder and fixed, at a second end thereof, to a spring carrier attached to the needle holder, and wherein the constant force spring is held in the pre-stressed state by a removable portion of the activation element.

7. The medicament delivery device of claim 5 , wherein the pre-stressed spring is a pull spring attached, at a first end thereof, to the cartridge holder and attached, at a second end thereof, to the needle holder.

8. The medicament delivery device of claim 1 , wherein the pre-stressed spring is a pull spring attached, at a first end thereof, to the main body and attached, at a second end thereof, to the needle holder.

9. The medicament delivery device of claim 8 , wherein the activation element is a detent disposed on an interior region of the cap.

10. The medicament delivery device of claim 9 , wherein the cap has pivotable side walls that are arranged to release the detent when the cap is squeezed.

11. The medicament delivery device of claim 9 , wherein the detent is releasable after rotationally aligning the cap with the needle holder.

12. The medicament delivery device of claim 1 , wherein the medicament delivery device contains the medicament cartridge and axial movement of the needle holder causes the needle to penetrate the penetrable barrier of the medicament cartridge.

13. The medicament delivery device of claim 12 , wherein the medicament cartridge contains a medicament.

14. The medicament delivery device of claim 1 , wherein the medicament delivery device is an auto-injector.

15. The medicament delivery device of claim 1 , wherein the pre-stressed spring is directly connected to the needle holder and to the main body.

16. A method of operating a medicament injection device having a cap, the method comprising: holding a pre-stressed spring of the medicament injection device in a pre-stressed state with an activation element that is directly coupled to the cap and to the pre-stressed spring or directly coupled to the cap and to a main body of the medicament injection device prior to any pulling of the cap in a distal axial direction away from the medicament injection device; and after holding the pre-stressed spring in the pre-stressed state, pulling the cap in the distal axial direction to remove the cap from the medicament injection device to release the pre-stressed spring, thereby decoupling the activation element from the main body if the activation element is directly coupled to the cap and to the main body in the pre-stressed state, or from the pre-stressed spring if the activation element is directly coupled to the cap and to the pre-stressed spring in the pre-stressed state, and causing proximal movement of a needle holder directly coupled to and carrying a needle, to cause a proximal end of the needle to pierce a penetrable barrier of a medicament cartridge.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2020
From: JUGL, MICHAEL; TEUCHER, AXEL; BLANCKE, STEFAN; HELMER, MICHAEL; SCHADER, MARC; BRAUN, SEBASTIAN
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 054123/0122 →
Priority Claims (1)
EP 15196693 · Nov 27, 2015 · regional
Continuity (1)
Related Publication 20180339111A1 · Nov 29, 2018